Form D · Pharmaceuticals
SCOLR Pharma, Inc.
Bellevue, WA · CIK 0000934936
Offering snapshot reported May 18, 2012 · SEC filing
- Reported sold
- $308K Offering amount: $1.35M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 4, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 18, 2012 | Initial | $308,000 | No comparison | 7 | SEC filing |
| Jun 30, 2011 | Amendment | $1,195,200 | $194,000vs Jun 23, 2011 | 82 | SEC filing |
| Jun 23, 2011 | Initial | $1,001,200 | No comparison | 62 | SEC filing |
| Mar 18, 2010 | Initial | $4,130,000 | No comparison | 123 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $94.5K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-178508
Issuer will pay a cash fee equal to 7% of the gross proceeds of the offering, and will issue a warrant to the placement agent for purchase of a number of commons shares equal to 5% of the shares into which the debentures sold are convertible.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Taglich Brothers, Inc. | 29102 | Taglich Brothers, Inc. · CRD 29102 |
Source: Form D, filed May 18, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mary Lou W. Arnett | Director |
| Randall L W Caudill | Director |
| Carl J. Johnson | Director |
| Richard M Levy | Executive |
| Herbert L. Lucas | Director |
| Bruce S Morra | Director |
| Wayne L Pines | Director |
| Jeffrey B. Reich | Director |
| Michael N. Taglich | Director |
| Stephen J. Turner | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
13400 Ne 20 Th Street Suite 44
Bellevue, WA, 98005
Bellevue, WA, 98005